Evidence map›Paper›PMID 37561026›Full record

ReviewProtein & cell2024

Ergothioneine and its congeners: anti-ageing mechanisms and pharmacophore biosynthesis.

Li Chen, Liping Zhang, Xujun Ye, Zixin Deng, Changming Zhao

Registry-linked trialOpen access · diamondAbstract readReview
In one paragraph

Review in Protein & cell, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06487546 (Repletion of Ergothioneine in Patients With Kidney Failure), which is not on this map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06487546 narecruitingnot on this mapstarted 2025, after this paper: background citation

Repletion of Ergothioneine in Patients With Kidney Failure

TypeinterventionalSponsorStanford UniversityRan2025 to 2030Enrolled28ConditionsEsrdArmsErgothioneine, Placebo
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Metabolic engineering ofSynthetic and systems biotechnology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. King Oyster Mushroom,Nutrients · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Li ChenDepartment of Geriatrics, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430072, China.ORCID 0000-0002-1394-2406
Liping ZhangKey Laboratory of Combinatory Biosynthesis and Drug Discovery, School of Pharmaceutical Sciences, Ministry of Education, Wuhan University, Wuhan 430072, China.ORCID 0000-0003-1064-7724
Xujun YeDepartment of Geriatrics, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430072, China.
Zixin DengDepartment of Geriatrics, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430072, China.
Changming ZhaoDepartment of Geriatrics, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan 430072, China.ORCID 0000-0002-8283-9621
Wuhan University · CN

Funding

National Key Research and Development Program of China 2018YFA0903200National Natural Science Foundation of China 32270032
6 · The paper itself

Abstract

Ergothioneine, Ovothiol, and Selenoneine are sulfur/selenium-containing histidine-derived natural products widely distributed across different organisms. They exhibit significant antioxidant properties, making them as potential lead compounds for promoting health. Increasing evidence suggests that Ergothioneine is positively correlated with healthy ageing and longevity. The mechanisms underlying Ergothioneine's regulation of the ageing process at cellular and molecular levels are beginning to be understood. In this review, we provide an in-depth and extensive coverage of the anti-ageing studies on Ergothioneine and discuss its possible intracellular targeting pathways. In addition, we highlight the recent efforts in elucidating the biosynthetic details for Ergothioneine, Ovothiol, and Selenoneine, with a particular focus on the study of their pharmacophore-forming enzymology.

Indexed as

ErgothioneineOrganoselenium CompoundsHistidinePharmacophoreErgothioneineHistidineOrganoselenium Compoundsselenoneineanti-ageingantioxidantbiosynthesisenzymologyErgothioneinelongevity

Identifiers

PMID37561026
PMCPMC10903977
OpenAlexW4385715730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.